ams introduces sensor reference design for blood pressure, vital signs for smart health and wearables
AS7024’s high performance solution for cuffless blood pressure measurement verified in independent clinical trial
Premstaetten, Austria -- ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, today announced the release of the first integrated vital sign sensor reference design based on its AS7024.The solution can perform accurate, fast and convenient 24/7 cuffless blood pressure measurement.
The new vital signs sensor reference design based on AS7024 integrates all the hardware components, including the AS7024, as well as the software required to implement blood pressure measurement, heart-rate measurement (HRM), heart rate variability (HRV) and electrocardiograms (ECG). The AS7024 sensor IC includes three LEDs, photodiodes, an optical front end and sequencer for HRM, and an analog front end for ECG in a low-profile 6.1mm x 2.7mm package. The reference design also enables calculated measurements of vagal tone and arterial elasticity, as well as skin temperature and skin resistivity via interfaces to external sensors.
The AS7024’s small form factor is particularly well suited for fitness bands, smart watches, sports watches and smart patches, in which board space is limited. It also opens the door for vital sign monitoring to a wider range of form factors and end markets such as automotive or personal health monitoring.
The AS7024 HRM operation is based on photoplethysmography (PPG), a proven technique that measures the pulse rate by sampling light modulated by the blood vessels, which expand and contract as blood pulses through them. Electrocardiography is a standard method for measuring the electrical pulses generated by the sinoatrial node of the heart.
Proprietary software in the AS7024 reference design, which was developed in collaboration with a partner, analyzes synchronized HRM and ECG measurements to calculate blood pressure. The accuracy of the AS7024’s blood pressure measurements has been validated in a clinical trial carried out at the Medical University of Graz in Austria, according to IEEE standard for cuffless wearable devices.
The results produced by the reference design were compared to a reference measurement taken with surgical-grade cuffed blood pressure measurement equipment. Across a total of more than 1,000 measurements on more than 100 subjects between 18 and 65 years of age, the AS7024 reference design was proven to be accurate to <± 7.5 mmHg for systolic pressure and to <± 5.5 mmHg for diastolic pressure.
”The AS7024 reference design with its blood pressure measurement algorithm marks a breakthrough in the field of personal health monitoring technology,” said Thomas Riener, Executive Vice-President for Color & Spectral Sensing at ams. “Smart wearable devices that use the AS7024 will be able to offer 24/7 blood pressure measurement that is accurate and dependable enough for many use cases. This will significantly improve the user’s experience, freeing them from the inconvenience and discomfort of regular cuff measurements and providing continuous measurements of their blood pressure, heart rate and heart activity in real-world conditions.”
The AS7024 vital signs sensor is available now in production volumes. Unit pricing is <$2.00 for the sensor frontend IC in order quantities of 1 million pieces.
The reference design and evaluation board for the AS7024 is available on request from ams and authorized sales representatives. It includes an ams Simblee Bluetooth® wireless module for connectivity, wireless charging capability and a smartphone app which displays measurements of heart rate, blood pressure, vagal tone and arterial elasticity.
Related news
-
Avery Biomedical Devices’ Nextgen Diaphragm Pacing Transmitter, Spirit, Earns FDA Approval – Now Available
Avery Biomedical Devices (Commack, NY), the global leader in high reliability diaphragm pacemakers, announced that its new diaphragm pacemaker transmitter, Spirit, has earned FDA approval and is now being offered to patients using its pacing system. This NextGen transmitter features a light-weight compact design with easy-to-use touch controls and offers precision-enhancing digital circuitry. Avery Chief Executive Officer Linda Towler stated, “At Avery, our R&D activities have always been focused on...
-
Flat Medical announced FDA 510(k) clearance of EpiFaith, the Epidural Safety Solution
Flat Medical Co., Ltd., the medtech company specializing in clinical safety solutions, announced it received 510(k) clearance from the U.S. Food and Drug Administration for its EpiFaith® syringe to deliver safe epidural locating solution. Based on the LOR technique, the EpiFaith® syringe is a physician-centered safeguard for epidural analgesia, which is indicated for painless labor, surgical anesthesia and chronic pain management. Compared with traditional practice that relies on the manual sense, EpiFaith&...
-
Christie Med Announces New Authorized Partner in Al Zahrawi for UAE Distribution of VeinViewer
As the leader in vein visualization technology throughout the world, Christie’s high-quality, made-in-the-USA, VeinViewer® Vision2 and VeinViewer® Flex, continue to provide customers with improved clinical outcomes such as increasing 1st stick success, decreasing medically not required PICC lines and enhancing patient satisfaction. We are committed to the continued growth of VeinViewer® as a standard of care and are excited to partner with Al Zahrawi as our authorized distributor for the...
-
Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed
First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on transforming women`s healthcare, today announced the initiation and first patient treated in a pivotal trial evaluating FemaSeed, a first in class, localized directional insemination product candidate for infertility. “For more than 20 years, current approaches to infertility treatment have been limited during the...
-
Sterile Medical Packaging Market Analysis | Global Demand Analysis & Opportunity Outlook 2026
Fast MR has recently published a report on Sterile Medical Packaging Market covering the impact of Covid-19 and recommendations to overcome them. The report provides insights regarding major demand driving factors and strategies of suppliers. This report provides detailed quantitative analysis of Sterile Medical Packaging Market and presents data for creating strategies to expand market growth and efficiency.The report delivers financial data of the market including growth, size, and market share. This report...
Customer comments
No comments were found for ams introduces sensor reference design for blood pressure, vital signs for smart health and wearables. Be the first to comment!